Literature DB >> 10667084

Adverse drug reaction monitoring and the Internet: evaluation of the use of the Internet by French Pharmacovigilance Centres and a non-exhaustive survey of websites of interest for collecting information about adverse drug reaction.

P Morel1, B Vandel.   

Abstract

The Internet, indisputably the most important source of information obtainable in real time, was long essentially the domain of researchers in the USA, but has now become more accessible to French Pharmacovigilance Centres (CRPV) and pharmaceutical companies. A questionnaire was sent to every CRPV to determine how the Internet was perceived in terms of pharmacovigilance activities and existing Websites of particular value to CRPVs were investigated. Analysis of the questionnaires revealed that 66.7 per cent of CRPVs are connected to the Internet but do not use it fully; 94 per cent of connected CRPVs use it essentially for access to a bibliographic database such as Medline (88 per cent), and none subscribes to discussion lists concerning alert messages on problems related to drugs and therapeutics. Non-connected CRPVs do not intend to use the Internet because of financial considerations, lack of time or the assumption that it is not beneficial in everyday situations. Apparently, many French CRPVs are not sufficiently aware of the importance of the Internet for professional purposes. A non-exhaustive list of sites on the Internet providing information likely to be of use to Pharmacovigilance Centres in their everyday activities is included. The Internet offers far greater possibilities than research for bibliographic references on Medline and could improve the manner in which pharmacovigilance is practised.

Entities:  

Mesh:

Year:  1999        PMID: 10667084

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  3 in total

1.  Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.

Authors:  Susan Colilla; Elad Yom Tov; Ling Zhang; Marie-Laure Kurzinger; Stephanie Tcherny-Lessenot; Catherine Penfornis; Shang Jen; Danny S Gonzalez; Patrick Caubel; Susan Welsh; Juhaeri Juhaeri
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

Review 2.  Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

Authors:  Kees van Grootheest; Linda de Graaf; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  The Effect of Laboratory Test-Based Clinical Decision Support Tools on Medication Errors and Adverse Drug Events: A Laboratory Medicine Best Practices Systematic Review.

Authors:  Nedra S Whitehead; Laurina Williams; Sreelatha Meleth; Sara Kennedy; Nneka Ubaka-Blackmoore; Michael Kanter; Kevin J O'Leary; David Classen; Brian Jackson; Daniel R Murphy; James Nichols; David Stockwell; Thomas Lorey; Paul Epner; Jennifer Taylor; Mark L Graber
Journal:  J Appl Lab Med       Date:  2019-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.